Technology | Stethoscopes | November 19, 2015

Smart ECG Stethoscope Attachment Improves the Cardio-Diagnostic Processes

FDA-cleared device combines ECG, digital auscultation and mobile app integration with any existing stethoscope

Rijuven, CardioSleeve for Pediatrics, FDA clearance, stethoscopes

Image courtesy of Rijuven

November 19, 2015 — Rijuven announced the launch of CardioSleeve for Pediatrics, the first U.S. Food and Drug Administration (FDA)-cleared device that adds electrocardiogram (ECG) capabilities to transform any existing stethoscope into a smart, mobile-connected device. The system is complete with three-lead ECG, digital auscultation and real-time digital analysis optimized for pediatric care. With CardioSleeve, pediatricians and clinicians can quickly and accurately visualize heart sound, analyze for arrhythmia or murmur, and identify heart failure.

Through the synchronization of digital heart sound with ECG, CardioSleeve for Pediatrics makes all-new functionality possible, such as advanced murmur detection analysis at times when restless patients, noisy environments and rapid heart rate can make examinations challenging. CardioSleeve murmur detection analysis aids in the diagnosis of pathological and physiological heart sounds in patients as young as infants, at heart rates up to 180 beats per minute.

Pediatricians and clinicians simply attach the CardioSleeve to an existing stethoscope. The device quickly and accurately acquires the digital acoustic and electric footprints of the heart and transmits them to a mobile device for real-time analysis. This allows for the creation of the Systolic Performance Index, a measure of ejection fraction, critical to identifying heart failure.

CardioSleeve for Pediatrics and its companion mobile app features:

  • Digital auscultation with ECG;
  • Murmur detection and analysis at beats up to 180 BPM;
  • High fidelity three-lead ECG;
  • Systolic Performance Index;
  • Digital caliper;
  • FDA clearance for both device and analysis;
  • HIPAA-secure data transfer and cloud-based electronic medical record (EMR);
  • Wireless Bluetooth connectivity;
  • IOS, Android and PC compatibility;
  • Easy attachment to any traditional stethoscope; and
  • Dry-contact and biocompatible surfaces.

CardioSleeve for Pediatrics is part of the Rijuven i2Dtx platform. i2Dtx is a comprehensive, portable, cloud-based medical device platform for heart, lung, vital signs, imaging and lab clinical assessments for any physical examination.

The i2DTX platform includes a CardioSleeve and connected devices including an otoscope, pulse ox, IR thermometer and blood pressure cuff. Optional additions include a weight scale, spirometer, ultrasound, and blood glucose monitor. All devices can be wirelessly deployed to assess patients at any point of care. i2Dtx connects vitals, diagnostic, and lab devices with live notes, real-time consults, high definition (HD) photos for visual exams and a complete EMR report both in the facility and remotely.

For more information: www.rijuven.com

Related Content

Plant-Based Diets Benefit Athletes' Heart Health, Endurance, Recovery
News | Cardiac Diagnostics | January 21, 2019
Meat-free athletes have already proven the performance-boosting power of a plant-based diet. Now, “Plant-Based Diets...
Sedentary Lifestyle Cancels Out Heart Benefits of Normal Weight
News | Cardiac Diagnostics | January 09, 2019
January 9, 2019 — Researchers at the University of Florida have found that low levels of physical activity can put he
Livongo Launches Applied Health Signals Product Category
News | Cardiac Diagnostics | November 30, 2018
Healthcare technology company Livongo recently announced the launch of its Applied Health Signals product category,...
HHS Releases Second Edition of Physical Activity Guidelines for Americans. #AHA2018 #AHA18
News | Cardiac Diagnostics | November 14, 2018
The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines...
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics | November 13, 2018
November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of
AMI READMITS Score Predicts Heart Attack Patients at High Readmission Risk
News | Cardiac Diagnostics | October 09, 2018
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those...
Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Weight Loss Drug Does Not Increase Cardiovascular Events
News | Cardiac Diagnostics | August 31, 2018
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI...
Acarix Presents CADScor System at ESC 2018
News | Cardiac Diagnostics | August 27, 2018
Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will be on display at...
NIH Ending Funding for Moderate Alcohol and Cardiovascular Health Trial
News | Cardiac Diagnostics | August 24, 2018
The National Institutes of Health announced in June it plans to end funding to the Moderate Alcohol and Cardiovascular...
Overlay Init